Serum cholinesterases are differentially regulated in normal and dystrophin-deficient mutant mice

Frontiers in Molecular Neuroscience

Volumn , Issue JUNE 2012, 2012, Pages

  Durrant, Andrea R ^a   Tamayev, Liliya ^a   Anglister, Lili ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; H P G axis; Mdx; Mouse serum; Muscular dystrophy; Orchidectomy; Testosterone

Indexed keywords

ANDROGEN; CHOLINESTERASE; CREATINE KINASE; DYSTROPHIN;

ANIMAL CELL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CASTRATION; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENOTYPE; GONADAL AGENESIS; GONADECTOMY; HYDROLYSIS; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE REGENERATION; NEUROENDOCRINE SYSTEM; NONHUMAN; ORCHIECTOMY; POSTNATAL GROWTH; PUBERTY;

EID: 84864018356     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2012.00073     Document Type: Article

References (54)

1. Anderson, J. E., Liu, L., Kardami, E., and Murphy, L. J. (1994). The pituitary-muscle axis in mdx dystrophic mice. J. Neurol. Sci. 123, 80-87.
2. Anglister, L., Etlin, A., Finkel, E., Durrant, A. R., and Lev-Tov, A. (2008). Cholinesterases in development and disease. Chem. Biol. Interact. 175, 92-100.
3. Austin, L., and Berry, W. K. (1953). Two selective inhibitors of cholinesterase. Biochem. J. 54, 695-700.
4. Ballard, C. G., Greig, N. H., Guillozet-Bongaarts, A. L., Enz, A., and Darvesh, S. (2005). Cholinesterases: roles in the brain during health and disease. Curr. Alzheimer Res. 2, 307-318.
5. Berman, H. A., Decker, M. M., and Jo, S. (1987). Reciprocal regulation of acetylcholiesterase and butyrlcholinesterase in mammalian skeletal muscle. Dev. Biol. 120, 154-161.
6. Brimijoin, S., and Hammond, P. (1988). Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay. J. Neurochem. 51, 1227-1231.
7. Chatonnet, A., and Lockridge, O. (1989). Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 260, 625-634.
8. Dale, H. H. (1914). The action of certain esters of choline, and their relation to muscarine. J. Pharmacol. Exp. Ther. 6, 147-190.
9. Darvesh, S., Hopkins, D. A., and Geula, C. (2003). The biology of butyrylcholinesterase. Nat. Rev. 4, 131-138.
10. Darvesh, S., Reid, G. A., and Martin, E. (2010). Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues. Curr. Alzheimer Res. 5, 386-400.
11. De Luca, A., Pierno, S., Camerino, C., Cocchi, D., and Camerino, D. C. (1999). Higher content of insulin-like growth factor-1 in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromuscul. Disord. 9, 11-18.
12. Dori, A., and Soreq, H. (2006). ARP, the cleavable C-terminal peptide of "readthrough" acetylcholinesterase, promotes neuronal development and plasticity. J. Mol. Neurosci. 28, 247-255.
13. Ecobichon, D. J., and Corneau, A. M. (1973). Pseudocholinesterase of mammalian plasma: physio-chemical properties and organo-phosphate inhibition in eleven species. Toxicol. Appl. Pharmacol. 24, 92-100.
14. Edwards, J. A., and Brimijoin, S. (1983). Effects of hypophysectomy on acetylcholinesterase and butyryl-cholinesterase in the rat. Biochem. Pharmacol. 32, 1183-1189.
15. Ellman, G. L., Courtney, K. D., Andres, V., and Featherstone, K. D. (1961). A new and rapid colorimetric determination of acetylcholinesterase. Biochem. Pharmacol. 7, 88-95.
16. Everett, J. W., and Sawyer, C. H. (1946). Effects of castration and treatment with sex steroids on the synthesis of serum cholinesterase in the rat. Endocrinology 39, 323-343.
17. Glesby, M. J., Rosenmann, E., Nylen, E. G., and Wrogemann, K. (1988). Serum, CK, calcium, magnesium, and oxidative phosporylation in mdx mouse muscular dystrophy. Muscle Nerve 11, 852-856.
18. Hahn, T., Desoye, G., Lang, I., and Skofitsch, G. (1993). Location and activities of acetylcholinesterase and butyrylcholinesterase in the rat and human placenta. Anat. Embryol. (Berl.) 188, 435-440.
19. Illsley, N. P., and Lamartiniere, C. A. (1981). Endocrine regulation of rat serum cholinesterase activity. Endocrinology108, 1737-1743.
20. Johnson, C. D., and Russell, R. L. (1975). A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64, 229-238.
21. Karpati, G., Carpenter, S., and Prescott, S. (1988). Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11, 795-803.
22. Katz, B., and Miledi, R. (1973). The binding of acetylcholine to receptors and its removal from the synaptic cleft. J. Physiol. 231, 549-574.
23. Koenigsberger, C., Hammond, P. I., and Brimijoin, S. (1998). Developmental expression of acetyl-and butyrylcholinesterase in the rat: enzyme and mRNA levels in embryonic dorsal root ganglia. Brain Res. 787, 248-258.
24. Lamartiniere, C. A. (1981). The hypothalamic-hypophyseal-gonadal regulation of hepatic glutathione S-transferase in the rat. Biochem. J. 198, 211-217.
25. Lamartiniere, C. A. (1986). Growth hormone modulates serum choline-sterase. Endocrinology 118, 1252-1254.
26. Layer, P. G. (1991). Cholinesterases during development of the avian nervous system. Cell. Mol. Neurobiol. 11, 7-33.
27. Layer, P. G., and Willbold, E. (1994). Cholinesterases in avian neurogenesis. Int. Rev. Cytol. 151, 139-181.
28. Layer, P. G., and Willbold, E. (1995). Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29, 1-94.
29. Leeuwin, R. S. (1965). Effect of androgenic and anabolic compounds on pseudocholinesterase activity in the liver and serum of the rat. Acta Endocrinol. 50, 391-402.
30. Lindzey, J., Wetsel, W. C., Couse, J. F., Stoker, T., Cooper, R., and Korach, K. S. (1998). Effects of castration and chronic steroid treatments on hypothalamic gonadotropin-releasing hormone content and pituitary gonadotropins in male wild-type and estrogen receptor-a knockout mice. Endocrinology 139, 4092-4101.
31. Lockridge, O., and Masson, P. (2000). Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk. Neurotoxicology 21, 113-126.
32. Lockridge, O., Eckerson, H. W., and La Du, B. N. (1979). Interchain disulfide bonds and subunit organization in human serum cholinesterase. J. Biol. Chem. 254, 8324-8330.
33. Lyles, J. M., Barnard, E. A., and Silman, I. (1980). Changes in the levels and forms of cholinesterases in the blood plasma of normal and dystrophic chickens. J. Neurochem. 34, 979-988.
34. Masson, P., and Lockridge, O. (2010). Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior. Arch. Biochem. Biophys. 494, 107-120.
35. Massoulié, J. (2002). The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11, 130-143.
36. Massoulié, J., Perrier, N., Noureddine, H., Liang, D., and Bon, S. (2008). Old and new questions about cholinesterases. Chem. Biol. Interact. 175, 30-44.
37. Mendel, B., and Rudney, H. (1943). Cholinesterases. 3. Specific tests for true cholinesterase and pseudo-cholinesterase. Biochem. J. 37, 473-476.
38. Meshorer, E., and Soreq, H. (2006). Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29, 216-224.
39. Muntoni, F., Torelli, S., and Ferlini, A. (2003). Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2, 731-740.
40. Oliver, L. J., Chatel, J.-M., Massoulie, J., Vigny, M., and Vallette, F. M. (1992). Molecular forms of acetylcholinesterase in dystrophic (mdx) mouse tissues. Neuromuscul. Disord. 2, 87-97.
41. Perelman, A., Abeijon, C., Hirschberg, C. B., Inestrosa, N. C., and Brandan, E. (1990). Differential association and distribution of acetyl-and butyrylcholinesterases within rat liver subcellular organelles. J. Biol. Chem. 265, 214-220.
42. Ralston, J. S., Rush, R. S., Doctor, B. P., and Wolfe, A. D. (1985). Acetylcholinesterase from fetal bovine serum. Purification and characterization of soluble G4 enzyme. J. Biol. Chem. 260, 4312-4316.
43. Sawyer, C. H., and Everett, J. W. (1946). Effects of various hormonal conditions in the intact rat on the synthesis of serum cholinesterase. Endocrinology39, 307.
44. Sawyer, C. H., and Everett, J. W. (1947). Cholinesterase in rat tissues and the site of serum non-specific cholinesterase production. Am. J. Physiol. 148, 675.
45. Settles, D. L., Cihak, R. A., and Erickson, H. P. (1996). Tenasin-C expression in dystrophin-related muscular dystrophy. Muscle Nerve 19, 147-154.
46. Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., and Barnard, P. J. (1989). The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science244, 1578-1580.
47. Silver, A. (1974). "Pseudocholine-sterases, " in The Biology of Cholinesterases, Vol. 36, eds A. Neuberger and E. L. Tatum (New York, NY: North-Holland Publishing Co.), 441.
48. Singh, J., O'Neill, C., and Handelsman, D. J. (1995). Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology 136, 5311-5321.
49. Skau, K. A. (1985). Acetylcholinesterase molecular forms in serum and erythrocytes of laboratory animals. Comp. Biochem. Physiol. C 80, 207-210.
50. Vogel-Höpker, A., Sperling, L. E., and Layer, P. G. (2012). Co-opting functions of cholinesterases in neural, limb and stem cell development. ProteinPept. Lett. 19, 155-164.
51. Zaccaria, M., Angelini, C., Dal Pont, O., Pegorara, E., Marchetti, M., and Scandellari, C. (1989). "Duchenne muscular dystrophy: lack of response to arginine test and low somatomedin-C levels, " in Growth Abnormalities, Serono Symposia Publications, Vol. 56, eds J. R. Bierich, E. Cacciari, and S. Raiti (New York, NY: Raven Press), 469-473.
52. Zatz, M., Betti, R. T., and Frota-Pessoa, O. (1986). Treatment of Duchenne muscular dystrophy with growth hormone inhibitors. Am. J. Med. Genet. 24, 549-566.
53. Zatz, M., Betti, R. T., and Levy, J. A. (1981a). Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency. Am. J. Med. Genet. 10, 301-304.
54. Zatz, M., Toledo, S., and Frota-Pessoa, O. (1981b). Suggestion for a possible mitigating treatment of Duchenne muscular dystrophy. Am. J. Med. Genet. 10, 305-398.